Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Cash from Financing Activities (2018 - 2025)

AdaptHealth has reported Cash from Financing Activities over the past 8 years, most recently at -$32.9 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$32.9 million for Q4 2025, up 38.98% from a year ago — trailing twelve months through Dec 2025 was -$302.2 million (down 51.89% YoY), and the annual figure for FY2025 was -$302.2 million, down 51.89%.
  • Cash from Financing Activities for Q4 2025 was -$32.9 million at AdaptHealth, up from -$56.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for AHCO hit a ceiling of $1.2 billion in Q1 2021 and a floor of -$156.6 million in Q2 2025.
  • Median Cash from Financing Activities over the past 5 years was -$20.7 million (2021), compared with a mean of $47.0 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 2007.94% in 2021 and later crashed 458.1% in 2024.
  • AdaptHealth's Cash from Financing Activities stood at -$21.7 million in 2021, then grew by 28.19% to -$15.6 million in 2022, then plummeted by 181.32% to -$43.9 million in 2023, then decreased by 23.06% to -$54.0 million in 2024, then skyrocketed by 38.98% to -$32.9 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$32.9 million (Q4 2025), -$56.6 million (Q3 2025), and -$156.6 million (Q2 2025) per Business Quant data.